On February 2, 2024, Implanet S.A closed the transaction. The company issued 76,335,877 New Shares at a issue price of ?0.0655 for a gross proceeds ?4,999,999.9435. Sanyou Medical now holds 74.56% of Implanet's capital and voting rights.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0712 EUR | -2.73% | +0.28% | +11.25% |
Apr. 10 | Implanet: first-quarter sales up slightly | CF |
Apr. 09 | Implanet S.A. Reports Revenue Results for the First Quarter of 2024 | CI |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+11.25% | 9.5M | |
+12.07% | 128B | |
-9.04% | 10.65B | |
+0.91% | 8.82B | |
+16.72% | 7.19B | |
+25.15% | 4.99B | |
+7.17% | 3.4B | |
-1.36% | 3.03B | |
-8.73% | 2.14B | |
-10.15% | 2B |
- Stock Market
- Equities
- ALIMP Stock
- News Implanet SA
- Implanet S.A. announced that it has received ?5 million in funding from Shanghai Sanyou Medical Co., Ltd